Cardiac Remodeling and Failure
Pawan K. Singal, Ian M.C. Dixon, Lorrie A. Kirshenbaum, Naranjan S. Dhalla
Springer Science & Business Media, Feb 28, 2003 - Medical - 545 pages
According to the World Health Report (2000 http:/ /www. who. int/whr), of the 55 million deaths worldwide in 1999, more than 16 million were secondary to car diovascular complications. With the prospect of world population increasing from the current level of 6 billion to 9 billion by the middle of this century, the burden of cardiac disease is going to increase astronomically. Furthermore, scientists are being challenged not only to reduce mortality, but also to improve quality of life. Thus, more than ever, intellectuals from different disciplines including biology, sociology, informatics and health care have to join forces to meet the mandate. The World Heart Congress with a focus on "Frontiers in Cardiovascular Health" held in Winnipeg during July 6-11, 2001, made a unique attempt to bring these specialists together to brainstorm and map out the course of action for cardiovascular research and health in the next century. Anytime there is a relative increase in the workload on the heart, there are adap tive myocardial as well as humoral responses. When these adaptations or remodel ing at the organ, subcellular or gene level, become inadequate for a proper tissue perfusion, the condition of heart failure ensues. Prevention of the factors leading to the relative increase in workload as well as a better understanding of the adap tive responses and their failure are some of the hopes to combat the morbidity and mortality due to heart failure.
What people are saying - Write a review
We haven't found any reviews in the usual places.
activity alterations angiotensin animals annexin apoptosis arrhythmias artery ATPase atrial fibrillation Biochem Biol Chem Ca2+-ATPase calcium cardiac hypertrophy cardiac myocytes Cardiac Remodeling cardiomyocytes Cardiovasc Res cardiovascular carvedilol cellular chronic Circ Res Circulation Clin clinical cocaine collagen congestive heart failure connexin contractile coronary cytokines decrease Dhalla diabetes diastolic digoxin dilated cardiomyopathy disease dysfunction effect endothelial enzyme failing heart failing human fibroblasts fibrosis Figure gap junction gene expression hemodynamic human heart hypertensive increased induced inhibition inhibitor intracellular ischemic isoforms isolated left ventricular mast cell mechanism membrane mice mitochondria mitochondrial mitral Mol Cell Cardiol mouse mRNA myocardial infarction myocardium myosin Na+-Ca2+ exchanger normal overexpression oxide palmitate pathways patients perfused phospholamban phosphorylation Physiol pressure protein levels rat heart receptor regulation renin role sarcoplasmic reticulum SERCA2a stimulation swine systolic therapy tion tissue TNF-a transgenic treatment troponin vascular vasodilation viral vivo volume overload